Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-(2-(diethylamino)ethyl0-2-9(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl)-3-methyl-6,7-dihydro-1h-pyrrolo(3,2-c)pyridin-4(5h)-one
2. Shr1020
1. 1044040-56-3
2. Shr1020
3. Shr-1020
4. Famitinib, (z)
5. 945380-27-8
6. Unii-768fw21j3l
7. 768fw21j3l
8. Famitinib [inn]
9. Famitinib [who-dd]
10. Chembl1278146
11. Shr 1020
12. 5-[2-(diethylamino)ethyl]-2-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-3-methyl-6,7-dihydro-1h-pyrrolo[3,2-c]pyridin-4-one
13. Compound 9 [pmid: 21028894]
14. Compound 9 (pmid: 21028894)
15. (z)-5-(2-(diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-6,7-dihydro-1h-pyrrolo(3,2-c)pyridin-4(5h)-one
16. 4h-pyrrolo(3,2-c)pyridin-4-one, 5-(2-(diethylamino)ethyl)-2-((5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-1,5,6,7-tetrahydro-3-methyl-
17. 4h-pyrrolo(3,2-c)pyridin-4-one, 5-(2-(diethylamino)ethyl)-2-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-1,5,6,7-tetrahydro-3-methyl-
18. 5-(2-(diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one
19. 5-(2-(diethylamino)ethyl0-2-9(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl)-3-methyl-6,7-dihydro-1h-pyrrolo(3,2-c)pyridin-4(5h)-one
20. 5-(2-diethylaminoethyl)-2-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-3-methyl-6,7-dihydro-1h-pyrrolo[4,5-c]pyridin-4-one
21. (3z)-3-((5-(2-(diethylamino)ethyl)-3-methyl-4-oxo-1h,4h,5h,6h,7h-pyrrolo(3,2-c)pyridin-2-yl)methylidene)-5-fluoro-2,3-dihydro-1h-indol-2-one
22. (3z)-3-({5-[2-(diethylamino)ethyl]-3-methyl-4-oxo-1h,4h,5h,6h,7h-pyrrolo[3,2-c]pyridin-2-yl}methylidene)-5-fluoro-2,3-dihydro-1h-indol-2-one
23. 5-(2-diethylaminoethyl)-2-((z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl)-3-methyl-6,7-dihydro-1h-pyrrolo(4,5-c)pyridin-4-one
24. Famitinib (standard)
25. Starbld0044024
26. Famitinib (shr1020)
27. Schembl137251
28. Gtpl7886
29. Ex-a6762
30. Bdbm50331023
31. Db11741
32. Hy-108713r
33. Da-63367
34. Ms-27081
35. Ns00072868
36. G14485
37. Q27077275
38. (z)-2-(5-fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-5-(2-diethylaminoethyl)-3-methyl-1,5,6,7-tetrahydropyrrolo-[3,2-c]pyridin-4-one
39. (z)-5-(2-(diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one
| Molecular Weight | 410.5 g/mol |
|---|---|
| Molecular Formula | C23H27FN4O2 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 68.4 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 695 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
21
PharmaCompass offers a list of Famitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Famitinib manufacturer or Famitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Famitinib manufacturer or Famitinib supplier.
PharmaCompass also assists you with knowing the Famitinib API Price utilized in the formulation of products. Famitinib API Price is not always fixed or binding as the Famitinib Price is obtained through a variety of data sources. The Famitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Famitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Famitinib, including repackagers and relabelers. The FDA regulates Famitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Famitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Famitinib supplier is an individual or a company that provides Famitinib active pharmaceutical ingredient (API) or Famitinib finished formulations upon request. The Famitinib suppliers may include Famitinib API manufacturers, exporters, distributors and traders.
Famitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Famitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Famitinib GMP manufacturer or Famitinib GMP API supplier for your needs.
A Famitinib CoA (Certificate of Analysis) is a formal document that attests to Famitinib's compliance with Famitinib specifications and serves as a tool for batch-level quality control.
Famitinib CoA mostly includes findings from lab analyses of a specific batch. For each Famitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Famitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Famitinib EP), Famitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Famitinib USP).
